CIK 0001745999 · Large accelerated filer
Beam Therapeutics Inc.
Sign in to watch- Ticker
- BEAM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 857-327-8775
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Former names
- Beam Therapeutics Inc.
- 4 Other disposition Director disposed of 400,000 shares (other)
- 4 Other disposition 10% owner disposed of 400,000 shares (other)
- 4 Open-market sale Director sold 12,045 shares at an average $106.34 ($1,280,897)
- 4 Open-market sale President & CSO sold 78,580 shares at an average $107.35 ($8,435,365)
- 4 Other acquisition Chief Executive Officer acquired 32 shares (other)
- 4 Open-market sale CFO sold 45,000 shares at an average $107.69 ($4,846,016)
- 4 Other disposition 10% owner disposed of 800,000 shares (other)
- 4 Other disposition Director disposed of 800,000 shares (other)
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- SC 13G Stake Amended Statement of Ownership
- S-3ASR Offering Registration Statement
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
Page 20 of 26 · 514 filings